Dandekar Atul, CSBO of Maze Therapeutics ($MAZE), made eight open market sales of company shares over the last year, totaling $3.6 million. His most recent sale occurred on February 27, 2026. These sales rank 2,392nd among 11,678 insiders in our database by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. He recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 6710 | $29.26 | 11,293.0000 | 48,119,444 | 37.27% | 0.01% |
| March 30, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Common Stock | 7500 | $10.42 | 18,003.0000 | 48,119,444 | 71.41% | 0.02% |
| March 30, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Stock Option (Right to Buy) | 7500 | $0.00 | 51,643.0000 | 48,119,444 | 12.68% | 0.02% |
| March 30, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 790 | $30.02 | 10,503.0000 | 48,119,444 | 7.00% | 0.00% |
| Feb. 27, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 3739 | $45.13 | 14,264.0000 | 48,119,444 | 20.77% | 0.01% |
| March 2, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | A | Restricted Stock Units | 19000 | $0.00 | 19,000.0000 | 48,119,444 | 9999.99% | 0.04% |
| March 2, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 48,119,444 | 9999.99% | 0.08% |
| Feb. 27, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 3761 | $45.72 | 10,503.0000 | 48,119,444 | 26.37% | 0.01% |
| Feb. 27, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Stock Option (Right to Buy) | 7500 | $0.00 | 59,143.0000 | 48,119,444 | 11.25% | 0.02% |
| Feb. 27, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Common Stock | 7500 | $10.42 | 18,003.0000 | 48,119,444 | 71.41% | 0.02% |
| Jan. 29, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 2800 | $45.01 | 10,503.0000 | 48,119,444 | 21.05% | 0.01% |
| Jan. 29, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Common Stock | 7500 | $10.42 | 18,003.0000 | 48,119,444 | 71.41% | 0.02% |
| Jan. 29, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 1200 | $43.18 | 16,803.0000 | 48,119,444 | 6.67% | 0.00% |
| Jan. 29, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 3500 | $44.04 | 13,303.0000 | 48,119,444 | 20.83% | 0.01% |
| Jan. 29, 2026 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Stock Option (Right to Buy) | 7500 | $0.00 | 66,643.0000 | 48,119,444 | 10.12% | 0.02% |
| Dec. 29, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Common Stock | 72400 | $10.42 | 82,903.0000 | 48,119,444 | 689.33% | 0.15% |
| Dec. 30, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Stock Option (Right to Buy) | 100 | $0.00 | 74,143.0000 | 48,119,444 | 0.13% | 0.00% |
| Dec. 29, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Stock Option (Right to Buy) | 72400 | $0.00 | 74,243.0000 | 48,119,444 | 49.37% | 0.15% |
| Dec. 30, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 100 | $40.36 | 10,503.0000 | 48,119,444 | 0.94% | 0.00% |
| Dec. 30, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | M | Common Stock | 100 | $10.42 | 10,603.0000 | 48,119,444 | 0.95% | 0.00% |
| Dec. 29, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 6035 | $41.13 | 10,503.0000 | 48,119,444 | 36.49% | 0.01% |
| Dec. 29, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | S | Common Stock | 66365 | $40.51 | 16,538.0000 | 48,119,444 | 80.05% | 0.14% |
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | Dandekar Atul | CSBO | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |